Intellia Therapeutics collects $15 mln
Intellia Therapeutics has received $15 million in Series A financing. Atlas Venture and Novartis led the round. Intellia develops therapeutic products for gene editing and repair.
18 November 2014•4 mins read
Intellia Therapeutics has received $15 million in Series A financing. Atlas Venture and Novartis led the round. Intellia develops therapeutic products for gene editing and repair.